Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., . . . Rungby, J. (2016). In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial. Front Aging Neurosci.
Citação norma ChicagoGejl, Michael, et al. "In Alzheimer’s Disease, 6-Month Treatment With GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial." Front Aging Neurosci 2016.
Citação norma MLAGejl, Michael, et al. "In Alzheimer’s Disease, 6-Month Treatment With GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial." Front Aging Neurosci 2016.